What is Capmatinib? | Uses, Side Effects, and More Capmatinib (brand name: Tabrecta) is a targeted cancer therapy used primarily in the treatment of non-small cell lung cancer (NSCLC). It…
Larotrectinib: A Targeted Therapy for TRK Fusion Cancer What is Larotrectinib? Larotrectinib is an oral cancer treatment designed to specifically target NTRK gene fusions, a rare genetic abnormality that can…
Gilteritinib: Targeted Therapy for FLT3-Mutated AML Gilteritinib is a breakthrough oral medication used in the treatment of acute myeloid leukemia (AML), specifically for patients with a FLT3 gene mutation. As…
Reviews
There are no reviews yet.